Literature DB >> 7947343

Role of insulin-like growth factors in steroid modulated proliferation.

B R Westley1, F E May.   

Abstract

The mechanism by which steroids influence cell proliferation is poorly understood although an understanding of this process might facilitate the development of strategies to modulate the tissue-specific activity of steroid hormones. In this article, the evidence that steroid hormones interact with the insulin-like growth factor (IGF) signal transduction pathway is reviewed for three different tissues. In osteoblasts, oestradiol stimulates the production of IGF-I which appears to act as an autocrine growth factor. In uterine tissue, oestradiol increases the synthesis of IGF-I in the stroma which then modulates the proliferation of epithelial cells although there is also evidence that oestradiol can modulate the sensitivity of uterine epithelial cells to IGFs. In breast cancer, oestrogens may increase IGF-II synthesis in epithelial cells, increase the sensitivity of breast cancer cells to IGFs (possibly by modulating type I IGF receptor levels) as well as resulting components of the IGF signal transduction pathway resulting in induction of immediate early genes. There therefore appears to be a variety of ways in which oestradiol interact with the IGF signal transduction pathway and these may be applicable to other malignant and normal tissues and other groups of steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947343     DOI: 10.1016/0960-0760(94)90109-0

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  14 in total

Review 1.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

Review 2.  Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients.

Authors:  S Sideris; F Aoun; C N Martinez; S Latifyan; A Awada; G Costante; T Gil
Journal:  J Endocrinol Invest       Date:  2016-01-19       Impact factor: 4.256

Review 3.  Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Authors:  Carlo Campagnoli; Françoise Clavel-Chapelon; Rudolf Kaaks; Clementina Peris; Franco Berrino
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07       Impact factor: 4.292

4.  Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.

Authors:  Arnulfo Quesada; Horacio E Romeo; Paul Micevych
Journal:  J Comp Neurol       Date:  2007-07-01       Impact factor: 3.215

5.  Photoperiod-induced differences in uterine growth in Phodopus sungorus are evident at an early age when serum estradiol and uterine estrogen receptor levels are not different.

Authors:  Adrien N Phalen; Ron Wexler; Jenifer Cruickshank; Sung-Un Park; Ned J Place
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2009-10-24       Impact factor: 2.320

6.  Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor).

Authors:  R Lu; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 7.  Breast cancer: further metabolic-endocrine risk markers?

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.

Authors:  K DeLellis; S Ingles; L Kolonel; R McKean-Cowdin; B Henderson; F Stanczyk; N M Probst-Hensch
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

9.  Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.

Authors:  J P Parisot; X F Hu; M DeLuise; J R Zalcberg
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.

Authors:  Nalo Hamilton; Diana Márquez-Garbán; Vei Mah; Gowry Fernando; Yahya Elshimali; Hermes Garbán; David Elashoff; Jaydutt Vadgama; Lee Goodglick; Richard Pietras
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.